Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ethema Health Corporation (GRST)
West Palm Beach, FL, US
Ethema Health Corporation, encompassing its various operating divisions, focuses on delivering addiction treatment services. The company's business activities are categorized into two primary segments: Rental Operations and In-Patient Services. Notably, it manages the Addiction Recovery Institute of America, a facility located in West Palm Beach, Florida. The entity previously operated under the name GreeneStone Healthcare Corporation before officially rebranding as Ethema Health Corporation in April 2017. Its corporate headquarters are likewise situated in West Palm Beach, Florida.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | -66.67% | -66.67% | -80.00% | -75.00% | -80.00% | -97.67% | -99.64% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+211.9% ★ Q4'25: +228.0% (vs Q4'24)
-
EPS growth Medical - Care Facilities: +19.2%+100.0% ★ Q4'25: +100.0% (vs Q4'24)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+10.3% Q4'25: +3.9% (vs Q4'24)
-
EBIT margin Medical - Care Facilities: +11.3%+0.0% Q4'25: -10.1% (vs Q4'24)
-
ROIC Medical - Care Facilities: +6.8%+0.0% Q4'25: -13.7% (vs Q4'24)
-
Share dilution Medical - Care Facilities: +0.0%+7.2% Q4'25: -100.0% (vs Q4'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×29.14× Q4'25: 369.35× (vs Q4'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
No beneficial ownership filings recorded.
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | STERLING INVESTMENT ADVISORS, LTD. | — -200.0K (-100.0%) | — -60.0 (-100.0%) | 0.00% -0.003 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-21 | Greene Eileen Maria | Other | P-Purchase | A | Common Stock | 10,000,000 | 0.00 | 5.0K | 1,099,199,593 | D | ↗ |
| 2024-11-20 | Greene Eileen Maria | Other | P-Purchase | A | Common Stock | 34,092,551 | 0.00 | 17.0K | 1,089,199,593 | D | ↗ |
| 2024-07-12 | Leon Shawn Edward | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 3,000,000,000 | 0.00 | 1.50M | 3,063,187,300 | — | ↗ |
| 2024-07-12 | Greene Eileen Maria | Other | P-Purchase | A | Common Stock | 1,000,000,000 | 0.00 | 500.0K | 1,050,107,042 | — | ↗ |
| 2024-06-20 | Greene Eileen Maria | Other | P-Purchase | A | Common Stock | 5,000,000 | 0.00 | 3.0K | 55,107,042 | — | ↗ |
| 2024-06-18 | Greene Eileen Maria | Other | P-Purchase | A | Common Stock | 5,000,000 | 0.00 | 3.0K | 50,107,042 | — | ↗ |
| 2024-06-06 | Greene Eileen Maria | Other | P-Purchase | A | Common Stock | 26,425,000 | 0.04 | 1.06M | 45,107,042 | — | ↗ |
| 2024-06-05 | Greene Eileen Maria | Other | P-Purchase | A | Common Stock | 10,005,000 | 0.04 | 400.2K | 18,682,042 | — | ↗ |
| 2023-12-22 | Greene Eileen Maria | — | — | D | Common Stock | 0 | 0.00 | — | 8,677,042 | — | ↗ |
| 2021-04-01 | Greene Eileen Maria | — | — | D | Series A Preferred | 40,000,000 | 0.00 | 40.0K | 0 | — | ↗ |
| 2018-11-21 | Leon Shawn Edward | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 28,350 | 0.08 | 2.2K | 80,417,584 | — | ↗ |
| 2014-11-01 | Sklar William L | Officer | — | D | Incentive Stock Option | 480,000 | 0.12 | 57.6K | 0 | — | ↗ |
| 2014-10-31 | Sklar William L | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Executive compensation
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Shawn E. Leon | Chairman, CEO & President | 20.0K | male |
| James Poage | Chief Financial Officer | — | male |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GRST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
